Abstract
Apoptosis of mammalian cell is under the control of a wide range of intracellular and extracellular factors-amongst them proteases, protein kinases, cytokines and the protein products of oncogenes and tumour suppressor genes. The c-myc proto-oncogene encodes an essential component of the cell's proliferative machinery and its deregulated expression is implicated in many cancers. Under certain conditions, c-Myc also acts as a potent inducer of apoptosis. We have developed a ‘switchable’ chimaeric c-Myc protein whose activity is dependent on the synthetic ligand, 4-hydroxytamoxifen. In cells expressing this switchable c-Myc, proliferation and apoptosis in cultured fibroblasts can be regulated by addition of 4-hydroxytamoxifen. We have further demonstrated the utility of a switchable gene transcription system for the induction of proteins with pro-apoptotic effect. Myc-induced apoptosis is inhibited by the action of certain cytokines or by expresson of exogenous proteins with anti-apoptotic potential such as Bcl-2. We show that inhibition of p53 using dominant negative molecules inhibits apoptosis induced by DNA damage but has little effect on Myc-induced apoptosis. Finally, we have also been able to modulate a relatively late stage in apoptosis using inhibitors of cysteine proteases. Our data suggest a model in which the integrated activities of several proteins with diverse molecular functions may determine whether a particular cell undergoes apoptosis but that, once the actual catalytic machinery is engaged, the apoptotic process is irreversible.
Similar content being viewed by others
References
Amati B, Dalton S, Brooks M, Littlewood T, Evan G and Land H (1992) Transcriptional activation by c-Myc oncoprotein in yeast requires interaction with Max. Nature 359: 423–426.
Amati B, Brooks M, Levy N, Littlewood T, Evan G and Land H (1993a) Oncogenic activity of the c-Myc protein requires dimerisation with Max. Cell 72: 233–245.
Amati B, Littlewood T, Evan G and Land H (1993b) The c-Myc protein induces cell cycle progression and apoptosis through dimerisation with Max. EMBO J 12: 5083–5087.
Askew D, Ashmun R, Simmons B and Cleveland J (1991) Constitutive c-myc expression in IL-3-dependent myeloid cell line suppresses cycle arrest and accelerates apoptosis. Oncogene 6: 1915–1922.
Berberich S, Hyde-DeRuyscher N, Espenshade P and Cole M (1992) max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. Oncogene 7: 775–779.
Bissonnette R, Echeverri F, Mahboubi A and Green D (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552–554.
Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H (1990) Sequence-specific DNA binding by the c-Myc protein. Science 250: 1149–1151.
Blackwood EM and Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211–1217.
Blackwood EM, Luscher B and Eisenman RN (1992) Myc and Max associate in vivo. Genes Dev 6: 71–80.
Braselmann S, Graninger P and Busslinger M (1993) A selective transcriptional induction system for mammalian cells based on Ga 14-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 90: 1657–1661.
Cohen J (1993) Overview: Mechanisms of apoptosis. Immunol Today 14: 126–130.
DePinho RA, Schreiber-Agus N and Alt FW (1991) myc family oncogenes in the development of normal and neoplastic cells. Adv Canc Res 57: 1–46.
Eilers M, Picard D, Yamamoto KR and Bishop MJ (1989) Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340: 66–68.
Eilers M, Schirm S and Bishop JM (1991) The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J 10: 133–141.
Enari M, Hug H and Nagata S (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78–81.
Evan G and Littlewood T (1993) The role of c-myc in cell growth. Curr Opin Genet and Dev. 3: 44–49.
Evan G, Wyllie A, Gilbert C, Littlewood T, Land H, Brooks M, Waters C, Penn L and Hancock D (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 63: 119–125.
Fanidi A, Harrington E and Evan G (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554–556.
Fletcher DS, Agarwal L, Chapman KT, Chin J, Egger LA, Limjuco G, Luell S, MacIntyre DE, EP, Thornberry NA et al. (1995) A synthetic inhibitor of interleukin-1 beta converting enzyme prevents endotoxin-induced interleukin-1 beta production in vitro and in vivo. J Interferon Cytokine Res 15: 243–248.
Freytag SO (1988) Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell. Biol. 8: 1614–1624.
Gerschenson LE and Rotello RJ (1992) Apoptosis: a different type of cell death. FASEB J 6: 2450–2455.
Harrington E, Fanidi A, Bennett M and Evan G (1994) Modulation of Myc-induced apoptosis by specific cytokines. EMBO J 13: 3286–3295.
Hermeking H and Eick D (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091–2093.
Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336.
Kato GJ, Barrett J, Villa GM and Dang CV (1990) An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10: 5914–5920.
Land H, Parada LF and Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602.
Littlewood T, Amati B, Land H and Evan G (1992) Max and c-Myc/Max DNA binding activities in cell extracts. Oncogene 7: 1783–1792.
Littlewood T, Hancock D, Danielian P, Parker M and Evan G (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nuc Acids Res 23: 1686–1690.
Los M, Vand CM, Penning LC Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W and Schulze OK (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81–83.
Mattioni T, Louvion JF and Picard D (1994) Regulation of protein activities by fusion to steroid-binding domains. Methods Cell Biol. 43: 335–352.
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63.
Pean L, Brooks M, Laufer E, Littlewood T, Morgenstern J, Evan G, Lee W and Land H (1990) Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol 10: 4961–4966.
Prendergast GC, Gawe D and Ziff EB (1991) Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65: 395–407.
Sakamuro D, Eviner V, Elliot KJ, Showe L, White E and Prendergast GC (1995) c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11: 2411–2418.
Shaulian E, Zeuberman A, Ginsberg D and Oren M (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 12: 5581–5592.
Stone J, de Lange T, Ramsay G, Jakobvits E, Bishop JM, Varmus H and Lee W (1987) Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7: 1697–1709.
Strasser A, Harris AW, Bath ML and Cory S (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331–333.
Vaux DL, Cory S and Adams KM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442.
Wagner A, Kokontis J and Hay N (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell-cycle arrest and the ability of p53 to induce p21(waf1/cip1). Genes and Dev 8: 2871–2830.
Wagner A, Le Beau M, Diaz M and Hay N (1992) Expression, regulation and chromosomal localization of the Max gene. Proc Natl Acad Sci USA 89: 3111–3115.
Wagner AJ, Small MB and Hay N (1993) Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 13: 2432–2440.
Walker NI, Harmon BV, Gobe GC and Kerr JF (1988) Patterns of cell death. Methods Achiev Exp Pathol 13: 18–54.
Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E and Spandidos DA (1987) Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer 56: 251–259.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Littlewood, T., McCarthy, N., Whyte, M. et al. Controllable genetic manipulation of apoptosis of cells in culture. Cytotechnology 22, 157–167 (1996). https://doi.org/10.1007/BF00353935
Issue Date:
DOI: https://doi.org/10.1007/BF00353935